Analysis of the osseointegrative force of a hyperhydrophilic and nanostructured surface refinement for TPS surfaces in a gap healing model with the Göttingen minipig by Seidling, Roland et al.
RESEARCH ARTICLE Open Access
Analysis of the osseointegrative force of
a hyperhydrophilic and nanostructured
surface refinement for TPS surfaces in a
gap healing model with the Göttingen
minipig
Roland Seidling1,2, Lars J. Lehmann1,3, Manuel Lingner1,4, Eckhard Mauermann1,5, Udo Obertacke1 and
Markus L. R. Schwarz1*
Abstract
Background: A lot of advantages can result in a high wettability as well as a nanostructure at a titanium surface on
bone implants. Thus, the aim of this study was to evaluate the osseointegrative potential of a titan plasma-sprayed
(TPS) surface refinement by acid-etching with chromosulfuric acid. This results in a hyperhydrophilic surface with a
nanostructure and an extreme high wetting rate.
Methods: In total, 72 dumbbell shape titan implants were inserted in the spongy bone of the femora of 18 Göttingen
minipigs in a conservative gap model. Thirty-six titan implants were coated with a standard TPS surface and 36 with
the hyperhydrophilic chromosulfuric acid (CSA) surface. After a healing period of 4, 8, and 12 weeks, the animals were
killed. The chronological healing process was histomorphometrically analyzed.
Results: The de novo bone formation, represented by the bone area (BA), is increased by approximately 1.5 times after
12 weeks with little additional benefit by use of the CSA surface. The bone-to-implant contact (BIC), which represents
osseoconductive forces, shows results with a highly increased osteoid production in the CSA implants beginning at
8 and 12 weeks compared to TPS. This culminates in a 17-fold increase in BIC after a healing period of 12 weeks. After
4 weeks, significantly more osteoid was seen in the gap as de novo formation in the CSA group (p = 0.0062). Osteoid
was also found more frequently after 12 weeks at the CSA-treated surface (p = 0.0355). The site of implantation,
intertrochanteric or intercondylar, may influence on the de novo bone formation in the gap.
Conclusions: There is a benefit by the CSA surface treatment of the TPS layer for osseointegration over an observation
time up to 12 weeks. Significant differences were able to be shown in two direct comparisons between the CSA and
the TPS surface for osteoid formation in the gap model. Further trials may reveal the benefit of the CSA treatment of
the TPS layer involving mechanical tests if possible.
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Background
According to Albrektsson et al., the implant surface
quality is one of six factors that influence the biological
response of a bone to an implant [1]. That is the reason
why today, the entire sectors of research are engaged in
various surface modifications. In these branches, the
important keywords are “nanostructure” and “wettability”
among many others. Both should lead to an improved and
accelerated osseointegration.
Nanoscale modification seems to be a very broad and
promising field. It can alter the chemistry and/or topo-
graphy of the implant surface, and cell culture studies
reveal that a range of nanoscale topography exists that
promotes the osteoinductive molecular program for ad-
herent osteoprogenitor cells [2]. This nanoscale topo-
graphy can stimulated macrophages [3] and provoke a
certain kind of reaction in many other cells [4].
The wettability of titan surfaces is another subject of
research. You can almost postulate that a surface with a
high wettability generally improves the osseointegrative
process. In vitro, a high wettability of a surface leads to a
clear reduction in cell number, but there is an increased
expression of osseophilic genes [5–8]. In vivo, you can
see an increased bone-to-implant contact (BIC) and an
improved mechanical stability at the beginning of the in-
growth process [9–14]. Some examples show that hydro-
philic surface refinements lose their force of wettability
when exposed to atmospheric air due to the oxidation or
adhesion of hydrocarbons [8, 15–18]. Therefore, a correct
storage of the implants until implantation is important. In
dental implantology, implants devices with a hyperhydro-
philic surface have been in use for several years and show
good long-term results.
In orthopedics, one main cause of implant failures is the
aseptic loosening [19] presumable triggered by debris
originating from the articulation components [20, 21].
Thus, debris are a focus of research [22]. At the side
of the implant components, which come in contact with
the bone, an early and tight anchorage may protect against
failure due to debris in the first time after implantation by
the so-called sealed interface [23] of the gaps between
implant and bone as described by Schmalzried et al. [24]
as “effective joint space”. This space may have a higher
impact in revision surgery when bone loss occurred due
to the excision of the former implant. Thus, the implant
surfaces should be able to induce filling up gaps, with the
demand for adequate models for preclinical test pro-
cedures. Long-term results are hard to evaluate with ani-
mal models in the research of joint replacement as we
expect life spans of several years or even decades. How-
ever, early and tight osseointegration is one of the most
important features of an implant surface, which might
be evaluable within several weeks after implantation in
preclinical tests.
In orthopedics, uncemented implantation systems may
have the advantage in the case of revision in comparison
to cemented implants because none or at least fewer bone
and no bone cement has to be removed. Other orthopedic
replacement systems wear an additional layer, for example
CaP, to enhance the bone ingrowth [25]. Further develop-
ments lead to resorbable CaP coating which enhances
osseointegration in the first time after implantation, thus
avoiding additional interfaces as the layer is gone after
some weeks [26].
As far as we know, no titan-surface with a nanostructure
and a high wettability is yet being used in orthopedic joint
replacement. The aim of this study was to examine the in-
fluence on the osseointegration of a porous titan plasma-
sprayed (TPS) implant surface after an etching procedure
with chromosulfuric acid [27–30]. After this procedure,
the chromosulfuric acid (CSA) surface exhibits a nano-
structure as well as a very high wettability [27–30]. In an
in vivo model, gaps between implant and bone served as
region of interest (ROI) in terms of osseoconductivity and
osseoinductivity [31] over a healing period from, respec-
tively, 4, 8, and 12 weeks.
Methods
The implants
For implantation, 72 non-functional, cylindrical dumbbell
shaped implants (length 30 mm) (Fig. 1) were machined
from TiAl6V4. They consisted of cylindrical ends for
fixation and a bar (15 mm) that enclosed the part of the
ROI. This bar was coated with a normal TPS layer [32]
with a thickness of approximately 310 μm, measured on a
representing implant by the manufacturer (DOT, Rostock,
Germany).
The working group of Prof. Jennissen, University Clinics
Essen, University of Duisburg-Essen, Germany, and the
Fa. Morphoplant GmbH, Bochum, Germany, completed
the modification of the implants.
Thirty-six implants had an untreated TPS surface. See
Fig. 2 for a SEM image. After cleaning them ultrasonically
in 80 % ethanol solution and gamma sterilization (25 kGy),
Fig. 1 Original CSA implant with the typical dumbbell shape
configuration leading to a circular gap around the middle thinner part
when inserted across a bone. The fixation in the bone is achieved by
anchoring the outer parts in the cortical bone initially by the press-fit
technique subsequently by osseointegration
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the implants were ready for use. Another 36 other implants
were surface enhanced with concentrated CSA by the
temperature jump method [27–30]. According to the sup-
plier information [17, 27, 30], the inner bars of the im-
plants should exhibit a TPS surface with a nanostructure
and an extremely high wettability after this procedure and
sterilization (Fig. 2). Because of the extensive tests of
the physical features and the stable etching procedure
performed by [16, 17, 27–30, 33–35], we did not carry out
further tests of the implants.
Animals and groups
The breeding company Ellegaard, Dalmose, Denmark,
supplied us with 18 skeletally mature, female Göttingen
minipigs (GMP). The mean age of the animals at the date
of the operation was 45 months (standard deviation (SD)
±6.66, min. 35, max. 57, median 42), and the mean weight
was 62 kg (SD ±5.25, min. 54, max. 73, median 62). After
biometrical sample size estimations, we formed two groups
consisting of nine GMPs each: a control group with 36
TPS implants and an experimental group with 36 CSA
implants. Each group was divided in three subgroups
corresponding to their postoperative observation time of
4, 8, and 12 weeks, respectively. In all subgroups, each
GMP received four implants of the same type according
to Schwarz et al. [26].
We chose a period of 4 to 12 weeks. The European
norm for the biological evaluation of medical devices
(EN 30993-6) requires 3 months for long-term testing.
Surgery and implantation
The surgery occurred under general anesthesia according
to Lehmann et al. and Schwarz et al. [36, 37]. This proce-
dure was very similar to the breeder’s recommendations
Fig. 2 SEM images of the surfaces in different magnifications taken 9 years after manufacturing the implants. a, b The TPS surface. In both magnifications,
there are structures reminding of molten metal splashes. c On microscale level, the CSA-treated TPS surface has different forms arguably depending on
the orientation of the crystal structure. d In a higher magnification, spherical patterns appear with dimension at the nanoscale level. (With permission from
Labor Lang, Nürnberg, Germany)
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[38]. But there is a huge wealth in general anesthesia and in
operational procedures of the GMPs, [26, 36–40] are only
few examples of methodical procedures.
The operational process was carried out as described
by Schwarz et al. [26]. Thomsen et al. already described
a similar approach for hip arthroplasty in the GMPs
in 1997 [41].
Two implants were inserted in the metaphyseal part of
each femur, one in the hip area (intertrochanteric) and
one in the knee area (intercondylar). Following the exact
measurement of the maximal outer diameter of the im-
plants, we drilled holes that were exactly 0.1 mm smaller
than the measurements. This ensured a press-fit implan-
tation [26, 39] (Figs. 3 and 4). In combination with the
special design of the implant, this procedure produces an
approximately 1-mm circumferential gap around the bar
of the implant which was designed to be filled by bone
structures during the healing period.
Sample preparation
After the GMP was killed we removed the femora and the
soft tissue around it. At the same time, we checked for
changes indicating inflammation and other irritation and
also verified the stability of the implants. The diaphyses of
the femora were cut orthogonally to its axis leaving a
safety distance of 1.3 cm between the cut and the implant.
The preparation for histological examination followed the
description of Donath and Breuer [42] for non-decalcified
specimens. Water and fat were eliminated over a period
of some weeks through an ascending ethanol sequence
starting at 40 % and ending at 100 %. This process was
completed using xylene. Afterwards, the specimens were
plasticized using polymethyl methacrylate (PMMA, Fa.
Merck, Darmstadt, Germany). Once they had completely
hardened, the PMMA blocks were trimmed down from
a size of approximately 10 × 10 × 10 cm blocks to a size
of 3 × 3 × 3 cm blocks with a special cutting system (Type
36/94, Fa. EXAKT, Norderstedt, Germany). The smaller
PMMA blocks were then cut into fine sections using a
minimal contact point cutting system (MCP, Fa.
EXAKT, Norderstedt, Germany).
During the cutting process, two reference points were
used for adjustment: the weight bearing axis of the
diaphysis and the axis of the implants itself. This way,
sections with an orientation strictly parallel to both axis
were created (Fig. 4). The two slices closest to the implant
axis were glued to slides and grinded down to a thickness
level of approximately 100 μm using a special grinding sys-
tem (400CS, Fa. EXAKT, Norderstedt, Germany). Of each
pair, the slices closest to the axis was stained by use of a
modified Masson-Goldner staining technique [43] (Fig. 5),
which allowed us to differentiate between mature bone
and osteoid, representing the precursor of bone. The
other slice was evaluated using fluorescence microscopy.
Histomorphometrical evaluation
All slices were blinded, so that an attribution to an indi-
vidual group of implants was impossible. The criterions of
exclusion for the histological preparations were defined,
and pictures of the remaining gaps were taken using a
LEICA DRC 300 FX microscope (Fa. LEICA Camera AG,
Solms, Germany). In the pictures, certain zones were
highlighted with the cursor: the ROI measuring 5 mm in
width and centered in the middle of the gap, the border of
the porous TPS /CSA surface as active area for osseocon-
duction, and the osteoid and the bone area, respectively
(Fig. 6). From these data, all information was automati-
cally calculated using the QWIN software (Fa. LEICA
Camera AG, Solms, Germany). The results were auto-
matically rendered as percentage relative to its parameter
of reference. Each gap was evaluated by three inde-
pendent observers, and the means were calculated for fur-
ther use in the statistical analysis. For self supervision, one
histological specimen was chosen and the observer re-
peated the measurements of this one specimen after every
20th gap. The results were then compared to prevent an
intraobserver failure.
Intravital staining
During the postoperative weeks, an intravital staining was
performed [43]. Each GMP received three scheduled intra-
muscular injections: tetracycline (26 mg/kg BW, Fa. Pfizer
GmbH, Karlsruhe, Germany) 19 days (Fig. 7), xylenol
Fig. 3 The operation wound which is widened by retractors. The
insertion was performed from the lateral site. The implant with a
diameter of approximately 8 mm (arrow) is placed according to the
measured depth of the bore; thus, both ends of the implant will be
surrounded by cortical bone by the press-fit technique
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orange (90 mg/kg BW, Fa. Waldeck GmbH & Co. KG,
Münster, Germany) 12 days, and calcein green (20 mg/kg
BW, Fa. Waldeck GmbH & Co. KG, Münster, Germany)
4 days prior to the killing. By excitation with light of the
corresponding wave lengths, the three observers evalu-
ated these slices in a semiquantitative way. For the overview
the so-called general score (min. 0 to max. 3), for the BA
the “amount score” (min. 0 to max. 3), and for bone turn-
over the “intensity score” (min. 0 to max. 5) were used.
Afterwards, the numerical mean of each of the three
scores was calculated and a descriptive statistic was
performed.
Statistical methods
All statistical calculations were made under the guidance
of the Department of Statistics and Empirical Research
of the Medical Faculty of Mannheim of the University
of Heidelberg using SAS 9.4. The level of significance
was 0.05.
Based on an estimated relative difference of 15 %, the
sample size calculation with a power of 80 % led to a
sample size of 11 implants. Taking into account the animal
model, the number of implants per subgroup was rounded
Fig. 4 The sections were x-rayed (20 kvp and 5 s) after the preparation of the MCP grinding machine in a Faxitron (Faxitron X-Ray Corporation,
Oregon, USA) in a contact X-ray technique. The figure shows a radiograph X-ray of the slices of the CSA preparation of the implant number 901
with the surrounding bony tissue. Seven sections were able to be made (a–g), and the most middle (d and e) were taken for further preparation
for histology and fluoroscopy. This implant lies in the metaphyseal part of the femur close to the hip
Fig. 5 Histological specimen (Masson-Goldner staining) of a CSA
implant (preparation 107) with the marked ROIs in the middle of
each gap (red boxes). This area was measured with a semiautonomously
working analysis program. The red dot marks the medial head at
the diaphyseal side of the implant. The implantation side was the
intercondylar part of the left knee. Note the demarcation of the gap
also after a healing period of 12 weeks
Fig. 6 The picture itself is made from 126 single pics to guarantee a
high resolution. As example, it shows an augmented detail of the left
distal knee gap of a CSA implant (preparation # 55) after a healing
period of 8 weeks. The blue box marks the ROI (equal to the red box of
Fig. 4), and the pink line shows the porous CSA surface. The dark blue
regions demonstrate the bone, and the red regions the osteoid areas.
The light green lines mark the cross section between bone and CSA
surface; equal to this, the turquoise lines show the cross section
for osteoid
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up to 12 implants. Thus, three animals per subgroup were
needed. In total, nine animals received 36 CSA and nine
animals 36 TPS implants.
Basically, each implant delivered two gaps, which
could possibly be evaluated. The mean of the proximal
and the distal gap was calculated; if only one gap was
measurable, single values were used for further statistical
processing. If both gaps had to be excluded, the implant
was lost for the statistical evaluation.
The means of measurements of the three independent
observers of the parameters osteoid ongrowth and BIC
in percent, as well as osteoid volume and BA in percent,
display the four dependent variables of this trial. Before
further processing, a Kolmogorov-Smirnov test has shown
that the data are not normally distributed and a Levene’s
test missed the homoscedasticity of the data. Consecu-
tively, the results of the four parameters were logarhyth-
mated after the addition of 1 (BA, osteoid volume) or
10 (BIC, osteoid ongrowth), respectively, before further
processing. Using the new values of the four parameters, a
three-way ANOVA with the “PROC MIXED Approach”
for repeated measures analysis [44] was calculated. After
this, pairwise comparisons between CSA and TPS were
made in a two-way ANOVA with the same SAS approach
for a healing period of 4, 8, and 12 weeks.
The different values of the length of the implant sur-
face were taken as absolute values of the measurement in
millimeters. Here, after a Kolmogorov-Smirnov-test for
normal distribution, a one-way ANOVA with a Bonferroni-
adjustment was calculated.
Results
The 18 GMPs survived the operation procedures and
were killed on the scheduled days. There were no obvious
complications during or after the operation procedures
like heavy bleedings, bone fracture, or infection of the im-
plant site. All animals were able to walk without an
apparent handicap at the latest 5 days after operation so
that the surgical model as well as the pain management
appeared to be effective and sufficient.
Several gaps or whole implants had to be excluded,
and a total of 93 out of the 144 gaps were evaluated.
The gaps were excluded for the following reasons: mal-
positioning of the implant with no standardized cover of
the gaps by bone (n = 24), delamination of the TPS layer
from the substrate (n = 24) and mistakes in histological
preparation (n = 3). In total, the criterions of exclusion
lead to five lost CSA and two lost TPS implants.
After the measurements, the calculated gap height of the
CSA implants were as follows: 1.26 mm, SD ±0.07 mm,
min. 1.08 mm, max. 1.46 mm, median 1.26 mm; and for
the TPS implants: mean 1.28 mm, SD ±0.05 mm, min.
1.21 mm, max. 1.45 mm, median 1.28 mm.
The “length” of the porous surface in the ROI for CSA
was 9.34 mm with an SD of ±1.42 mm (min. 7.18 mm,
max. 13.26 mm, median 9.01 mm). In the TPS group, the
values were as follows: mean 10.57 mm, SD ±1.33 mm,
min. 8.31 mm, max. 14.50, and median 10.60 mm, which
was significantly different (p < 0.0001) from the results of
the CSA group.
Statistical results overall
The rawdata of the histomorphometric analyses is pro-
vided as Additional file 1. Perusing the results of the
ANOVA overall, the p values (Table 1) show that signifi-
cant differences between the means of CSA and TPS can
be found in the data stock for osteoid ongrowth, the
BIC, and for osteoid volume. The implantation site (lo-
cation) shows significances for the BA (Table 1).
In the further course, the results of the post hoc tests of
the interaction implant type and postoperative time deliver
a more precise explanation of the osseointegration for the
corresponding parameters (Table 2).
Results of the osseoconduction
The ANOVA revealed two significant results for osteoid
ongrowth (p = 0.0039) and the BIC (p = 0.0411). The
osseoconduction is determined by the contact between
the porous implant surface and the osteoid or the bone,
in our experiment called “osteoid ongrowth” (Fig. 8a) and
the “BIC” (Fig. 8b). Although a significant difference is ex-
pected for both parameters, only for the osteoid ongrowth
a significant difference between CSA and TPS could be
shown in the pairwise comparisons of the corresponding
healing period.
Fig. 7 After illumination of the ROI with a wavelength of 370 nm,
the fluorescence of tetracycline in the bone matrix is shown. The
arrow marks a “very high” intensity, “5” as numerical value. The slice
of preparation 133 belongs to a CSA implant after 12 weeks of healing,
so that the intensity can be seen as activity of bone maturation at the
65th postoperative day. The stars mark the implant surface which is
here exemplarily in contact to the bone matrix
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After 4 weeks of healing, 1.32 % (SD ±1.89) of the
CSA surface is in contact to the osteoid. In the TPS
group, there is a coverage of 0.15 % (SD ±0.26). After
8 weeks, the difference between CSA and TPS spreads
but without a significance: CSA (8.67 %, SD ±10.26) and
TPS (0.46 %, SD ±1.08). After 12 weeks of defect heal-
ing, this difference (CSA, 8.10 %, SD ±5.39/TPS, 1.18 %,
SD ±1.74) shows a significance with p = 0.0355.
For the BIC, the means are as follows: after a healing
period of 4 weeks, there is an increased amount of bone
in contact with the CSA surface (0.85 %, SD ±1.83) in
comparison to TPS (0.01 %, SD ±0.03). In both groups,
both these values increase, but much faster for CSA
(8 weeks, 2.47 %, SD ±4.03/12 weeks, 9.00 %, SD ±8.58)
than in the TPS group (8 weeks, 0.53 %, SD ±1.34/
12 weeks, 0.52 %, SD ±0.83). After 12 weeks, the
amount of BIC is 17-fold increased on the CSA surface
in comparison to TPS. But this difference failed to show
a significant difference.
Results of the de novo bone formation
The calculated p values of the ANOVA of the de novo
bone formation are p = 0.0327 for the osteoid (Fig. 9a) and
p = 0.2951 for the BA (Fig. 9b). After a healing period of
4 weeks, there is a significantly increased (p = 0.0062)
amount of osteoid for CSA (4.98 %, SD ±1.96) in
comparison to TPS (1.89 %, SD ±0.85). These initial
high values for CSA decrease about 40 % at 8 weeks
(4.51 %, SD ±2.88) to 12 weeks (3.16 %, SD ±1.88).
In contrast, the osteoid volume for TPS increases
slowly (8 weeks, 1.97 %, SD ±1.70/12 weeks, 2.41 %,
SD ±2.25).
While the BA for CSA remains nearly constant
(4 weeks, 7.83 %, SD ±5.60/8 weeks, 8.55 %, SD ±5.21/
12 weeks, 8.78 %, SD ±5.92), it decreases slowly for TPS
(4 weeks, 7.20 %, SD ±4.51/8 weeks, 6.61 %, SD ±3.58/
12 weeks, 5.93 %, SD ±4.25). Here, no significant diffe-
rence could be shown.
Intravital staining
The results of the intravital staining demonstrate that
bone turnover took place in the gaps. We were able to
see a positive reaction resulting from the integration of
the pigments in the bone matrix during the calcification
for each date of assessment. Thus, bone metabolism in
the gap was proven for every implant till the end of the
trial at 12 weeks in similar degrees (Fig. 10).
Discussion
The aim of the study was the investigation of the osseo-
integration of a newly created nanostructured and hyper-
hydrophilic surface refinement for TPS surfaces. The
acceleration of osseointegration is the goal of several pre-
vious and may be future studies, as there is a growing
need for revision surgery as a necessary way of treatment.
In revision surgery, gaps between bone and implants will
occur more frequently than in primary surgery as the
bone stock is reduced depending on, for example, the
loosening of the implant or a previous implantation with
bone cement. However, also in primary implantation of
artificial joints, early bone integration may induce longer
survival as the “effective joint space” [24] will be closed
early and sealed. Thus, the investigation assessment of
CSA surfaces on titanium implants in a gap model seemed
to be justified.
Methods
In comparison to human conditions, the GMP as a large
laboratory animal for research offers a great similarity in
metabolism, bone density, mineralization, and recovery
rate [41, 45]. In this animal, the general anesthesia [38, 40]
Table 1 The calculated p values of the three-way ANOVA using
the “MIXED Procedure” of SAS
Osteoid
ongrowth
BIC Osteoid
volume
BA
Implant type 0.0039 0.0411 0.0327 0.2951
Postoperative time 0.0698 0.1418 0.7630 0.8434
Location 0.1267 0.2080 0.1269 0.0025
Implant type × postoperative time 0.2139 0.2310 0.7908 0.8516
Implant type × location 0.7979 0.5282 0.7572 0.0130
Corresponding to the level of significance of 0.05, several significant
differences are found
Table 2 The table displays the means and standard deviation of
the pairwise comparisons
Parameters Healing period
(weeks)
CSA TPS p values
Osteoid
ongrowth
4 1.32 % ±1.94 0.15 % ±0.26 0.0859
8 8.67 % ±10.26 0.46 % ±1.08 0.1051
12 8.10 % ±5.39 1.18 % ±1.74 0.0355
BIC 4 0.85 % ±1.83 0.01 % ±0.03 0.1953
8 2.47 % ±4.03 0.53 % ±1.34 0.4694
12 9.00 % ±8.58 0.52 % ±0.83 0.1154
Osteoid
volume
4 4.98 % ±1.96 1.89 % ±0.85 0.0062
8 4.51 % ±2.88 1.97 % ±1.70 0.2691
12 3.16 % ±1.88 2.41 % ±2.25 0.5014
BA 4 7.83 % ±5.60 7.20 % ±4.51 0.7026
8 8.55 % ±5.21 6.61 % ±3.58 0.5530
12 8.78 % ±5.92 5.93 % ±4.25 0.4700
Values are shown in percentages to the corresponding parameters as well as
the standard deviation in percentages. P values are calculated in a two-way
ANOVA using the “MIXED Procedure” of SAS
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as well as some operation procedures are well-established.
In the present study, a solid model was used, which could
be validated for press-fit implantation of cylindrical
implants and converted into a gap model as described pre-
viously [39]. Holes in cortical bone greater than 400 μm
are primarily filled with woven bone [46]. In animals, the
inflammatory phase takes place during the first few days,
and the reparative phase with woven bone occurs after
2 weeks [25]. Afterwards, a reorganization takes place and
a lamellar bone with an functional orientation is formed
[25]. The chosen gap width of approximately 1 mm is
close to the critical gap size, which shows a delayed brid-
ging by woven bone [25] referred to [47].
This way and by reducing the size of the ROI to 5 mm,
representing one third of the total gap length, we were able
to evaluate the de novo formation of bone (BA) in a
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Fig. 8 a Osteoid ongrowth: In the ANOVA, a p value of 0.2139 (Table 1) was calculated for the interaction implant type and postoperative time.
The rhombi mark the means, and the crosses the medians of each group. The boxes display the interquartile range. After 12 weeks of defect
healing, you can find a significant difference (*p = 0.0355) (Table 2). b BIC: A p value of 0.2310 (Table 1) was calculated in the ANOVA. In the
pairwise comparison, you can find no significant difference between CSA and TPS (Table 2). But after a healing period of 12 weeks, the amount
of BIC is 17-fold increased at the CSA surface
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conservative model. This formation was not influenced by
regenerating processes based on existing bone at the edge
of the gap. Sumner et al. [48] postulated that a bio-
active surface (recombinant bone morphogenetic pro-
tein) could induce an increased osseointegration on a
non-bioactive surface which is implanted in the same ani-
mal but in a different location. This effect seemed to be
independent of the regenerative ability of the bone mor-
phogenetic proteins but also affected by factors resulting
from the regenerating bone around the bioactive surface.
To prevent such an effect from happening, every experi-
mental animal in our study received one type of implant.
Although this procedure has advantages, it could lead to
other problems. If a noticeable osseointegrative reaction
in a certain animal took place, it is allocated to either the
test or the control group. Thus, a single animal could be-
come a source of inaccuracy. Alternatively, when test and
control implants are placed in the same experimental ani-
mal, an outlier would be allocated to both groups. Thus, it
would not influence the pairs made in the evaluation.
The calculated gap height after the measurements is
very comparable in both groups without a significant
difference. Assigning these results to the corresponding
surfaces, hardly any difference between both could be
found (CSA 1.26 mm, SD ±0.07/TPS 1.28 mm, SD ±0.05).
Thus, the standardized position of the ROI is justified and
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Fig. 9 a Osteoid volume: In the ANOVA, a p value of 0.7908 (Table 1) was calculated for the interaction implant type and postoperative time. The
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the used gap model can be seen as stable with comparable
conditions for both groups.
Another interesting parameter is the “length” of the
porous surface in the ROI. This parameter was primarily
used as a reference for the calculation of the ongrowth.
The comparison of the groups revealed a very interesting
fact: the means of the CSA (9.34 mm, SD ±1.42 mm) are
about 1.2 mm shorter than in the TPS group (10.57 mm,
SD ±1.33 mm), with p < 0.0001 a significant difference.
These measurements could lead to the assumption that
the CSA etching may induce a material-consuming process
which destroys matter and could end up in a reduction of
the surface area on a microscale level. But it has to be
considered that the etching with chromosulfuric acid pro-
duces a characteristic surface configuration on a nanoscale
level leading to an enhancement of the surface area [30]
by spheroidic bubbles at nanometer scale in diameter
(Fig. 2).
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The histomorphometry is still seen as the “golden stan-
dard” for the evaluation of undecalcified slices of bone
[49, 50]. By the use of the Masson-Goldner staining, a dif-
ferentiation between osteoid and bone is possible. In
combination with the timeframe (4, 8, 12 weeks), the
chronological process of the osseointegration is evident.
All measurements on the slices are two-dimensional,
but in reality, the parameters exhibit three dimensions.
But this is a common procedure in histomorphometry
and the results have a high correlation to 3D [51, 52].
Theoretically, the intravital staining should give add-
itional information of the dynamic process of osseointe-
gration. Because of the semiquantitative scores, the data
does not have the validity of an exact histomorphometrical
analysis. But it shows that bone turn over took place over
the assessed period.
Criterions of exclusion
The criterions of exclusion for the slices were rigor-
ous to obtain standardized gaps. Only slices with a
detectable successful press-fit implantation and a
straight border of spongy bone were evaluated. If a
gap was positioned directly next to the cortical bone,
it was excluded because here, an increased bone for-
mation into the gap could be assumed. In some
slides, the TPS and the CSA surfaces were peeled off
the TiAl6V4 body material. Later on, a CSA and TPS
implant was checked exemplarily by the manufacturer
microscopically. According to this data, one may
assume that both the CSA and the TPS surfaces have
an adhesion strength of at least 40 MPa [32] on the
TiAl6V4 base material. This power could not be in a
regeneration process. It must be assumed that this
phenomenon arises during the cutting process using
the MCP machine. Perhaps in several cases, there was a
correlation between an increased noise and vibration and
emitted sparks. Thus, thermic damage of the porous
surface as well as the surrounding PMMA matrix can-
not be excluded. A force-induced delamination in vivo is
not likely as the implant is without function in this model.
The grinding procedure for thinning the slides for the
histological analysis can also weaken the interface be-
tween the TPS layer and the substrate as mentioned by
the manufacturer [53]. The intended sample size of 11
was reduced to 9 evaluable implants for CSA-4-weeks and
to 10 for CSA-8-weeks and TPS-12-weeks. In the other
three cases, all implants were usable for examination.
Histological data
A CSA preparation on a sandblasted-large-grit titanium
surface was tested in a pilot study by [30, 54] with a heal-
ing period of 4 weeks in dog mandibels. The relative bone
density in a distance from <1 mm and >1 mm around the
implants was increased in both cases by approximately
100 % [30, 54].
As shown in Fig. 8a, b, the CSA surface shows an
osseoconductive property throughout the study. On closer
inspection, the amount of the osteoid ongrowth (CSA)
remains static from the 8th week on. In a synopsis with
the progression of the BIC, it seems that between week 8
and week 12, a high calcification process begins leading to
a BIC 17 times higher at the CSA surface after a healing
period of 12 weeks in comparison to TPS. A significant
difference could only be shown for the osteoid ongrowth
after a healing period of 12 weeks (p = 0.0355). At first
sight, the means seem to display a serious advantage by
the CSA surface. At second sight, the further statistical
parameter show some “positive” outliers and a broad vari-
ance of both ongrowth parameters.
Figure 9a, b shows the chronological process of the de
novo bone formation with less difference in the pairwise
comparisons than in the ongrowth parameters. Here,
fast CSA-induced osteoid formation shows significance
after 4 weeks of healing before it starts to decrease till
the 12th week. But at this time, the osteoid volume of
CSA is still 1.3 times higher than in the TPS group. The
bone area (BA) for CSA is increasing constantly while
the values decrease for the TPS. After 12 weeks, the BA
for CSA is 1.5 times higher, but without significance.
A similar regeneration behavior is reported in the same
gap model. For a CaP-enhanced surface, the BIC shows an
increase after 4 (12.5 %) and 8 weeks (32 %) while for
TPS, the values stays low (0.01 % at 4 and 0.7 % at
8 weeks). For the BA, hardly any difference could be
detected [39].
In the ANOVA the term “location” (p = 0.0025) and
the interaction “implant type × location” (p = 0.0130)
of the bone volume gives an indication for significant
differences, each time with an increased bone formation
at the intertrochanteric (hip) insertion point in compa-
rison to the intercondylar (knee). Maybe their different
bone stocks provide different osseointegrative potential.
Because this phenomenon is not reproducible for the
other three parameters, the discussion of this aspect will
be postponed.
One surface refinement similar to the CSA etching is
the sandblasted, large-grit, and acid-etched (SLA)-pro-
cessing. These implants exhibit a microrough surface
[55] and after a correct storage a low DCA of appro-
ximately 0° [56] and show an accelerated BIC formation
[9, 12] with an increase between 1.2 to 1.5 times in com-
parison to a conventional storage of SLA. In comparison
to Jennissen and Lüers [17] and Alfarsi et al. [56] SLA
displays comparable surface properties to TPS, with re-
gard to roughness and wettability. In a removal torque
test, little difference could be noticed between the SLA-
and the TPS surface [57]. So the difference in BIC is
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approximately 17 times higher in the CSA group compared
to the TPS group, which is remarkable in the presented
study. This is perhaps due to the high wetting rate [33] in
the composition of the nanostructures and needs further
study.
A positive effect of the CSA surface on the osseointe-
gration can be seen over the assessed time period up to
12 weeks. However, only 2 of 12 pairwise comparisons
between the TPS and the CSA groups showed significant
differences for both parameters: the osteoid ongrowth and
the osteoid volume. At first sight, the ongrowth parame-
ters seem to display a serious advantage on the osseoin-
tegration. At second sight, the statistical parameters show
some “positive” outliers and a broad variance of both
ongrowth parameters. It seems that the CSA surface as
well as the TPS surface have no manifest ability of brid-
ging a gap near the critical gap size of 1 mm [25] referred
to [47] in the assessed healing period up to 12 weeks. For
a hydroxyapatite coating, a sufficient sealing effect could
be shown from 3 weeks after surgery [58, 59]. However
the use of a titan monolayer surface eliminates the risk of
the destruction of an additional layer, as described by
Soballe as the “degradability in biological environment”
[25].
For a regular TPS surface, a BIC of approximately 22 %
after a press-fit implantation in a Göttingen minipig could
be shown [26]. Despite of the data of the gap model, we
suggest that results received from mechanical testing of
the CSA surface could generate very interesting results,
because the surface could develop its osseoconductive
potential when it makes direct contact to the existing bone.
This could be analyzed in a press-fit model with pull-out
tests as described previously [26] or by the use of screw
shape implants with removal torque tests [60, 61].
Conclusions
The presented study leads to the conclusion that there is a
benefit by the CSA surface treatment of the TPS layer for
osseointegration over an observation time up to 12 weeks.
Statistical proof was able to be shown in two direct com-
parisons between the CSA and the TPS surface in the gap
model in terms of osteoid.
Further trials may reveal the benefit of the CSA treat-
ment of the TPS layer particularly involving mechanical
tests if possible.
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